Health care costs and utilization rates for children with pervasive developmental disorders in North Dakota from 1998 to 2004: Impact on medicaid

Journal of Child Neurology

Volumn 24, Issue 2, 2009, Pages 140-147

  Peng, Chun Zi ^a   Hatlestad, Preston ^a   Klug, Marilyn G ^b   Kerbeshian, Jacob ^a   Burd, Larry ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Autism; Comorbidity; Health care costs; Medicaid

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL DISEASE; OUTPATIENT CARE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COHORT STUDIES; DELIVERY OF HEALTH CARE; ECONOMICS, PHARMACEUTICAL; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAID; MENTAL DISORDERS; NORTH DAKOTA; STATISTICS, NONPARAMETRIC; UNITED STATES; YOUNG ADULT;

EID: 59649106384     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808321059     Document Type: Article

References (28)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Eapen V., Mabrouk AA, Zoubeidi T., et al. Prevalence of pervasive developmental disorders in preschool children in the UAE. J Trop Pediatr. 2007;53(3):202-205.
3. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66(suppl)10:3-8.
4. Matson JL, Benavidez DA, Compton LS, et al. Behavioral treatment of autistic persons: A review of research from 1980 to the present. Res Dev Disabil. 1996;17(6):433-465.
5. Bryson SE, Rogers SJ, Fombonne E. Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Can J Psychiatry. 2003;48(8):506-516.
6. Burd L., Kerbeshian J., Westerland A., et al. Prospective long-term follow-up of patients with pervasive developmental disorders. J Child Neurol. 2002;17(9):681-688.
7. Keen D., Ward S. Autistic spectrum disorder. a child population profile. Autism. 2004;8(1):39-48.
8. Bonde E. Comorbidity and subgroups in childhood autism. Eur Child Adolesc Psychiatry. 2000;9(1):7-10.
9. Leyfer OT, Folstein SE, Bacalman S., et al. Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. J Autism Dev Disord. 2006;36(7):849-861.
10. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: An update. J Autism Dev Disord. 2003;33(4):365-382.
11. Mandell DS, Cao J., Ittenbach R., et al. Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. J Autism Dev Disord. 2006;36(4):475-485.
12. Shimabukuro TT, Grosse SD, Rice C. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord. 2007;38(3):546-552.
13. Liptak GS, Stuart T., Auinger P. Health care utilization and expenditures for children with autism: Data from U. S. national samples. J Autism Dev Disord. 2006;36(7):871-879.
14. Croen LA, Najjar DV, Ray GT, et al. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006;118(4):e1203-e1211.
15. Leslie DL, Martin A. Health care expenditures associated with autism spectrum disorders. Arch Pediatr Adolesc Med. 2007;161(4):350-355.
16. Jarbrink K., Fombonne E., Knapp M. Measuring the parental, service and cost impacts of children with autistic spectrum disorder: A pilot study. J Autism Dev Disord. 2003;33(4):395-402.
17. Simpson L., Owens PL, Zodet MW, et al. Health care for children and youth in the United States: Annual report on patterns of coverage, utilization, quality, and expenditures by income. Ambul Pediatr. 2005;5(1):6-44.
18. Frank RG, Goldman HH, Hogan M. Medicaid and mental health: Be careful what you ask for. Health Aff (Millwood). 2003;22(1):101-113.
19. Deal LW, Shiono PH Medicaid managed care and children: An overview. Future Child. 1998;8(2):93-104.
20. Burd L., Fisher W., Kerbeshian J. A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry. 1987;26(5):700-703.
21. Burd L., Kerbeshian J., Klug MG, et al. A prevalence methodology for mental illness and developmental disorders in rural and frontier settings. Int J Circumpolar Health. 2000;59(1):74-86.
22. Newacheck PW, Inkelas M., Kim SE Health services use and health care expenditures for children with disabilities. Pediatrics. 2004;114(1):79-85.
23. Grosse S., Shimabukuto T. Direct medical costs of autism in a privately insured population - 2002. AcademyHealth 2005. Annual Research Meeting abstracts. http://www.academyhealth.org/2005/childhealth.pdf.
24. Ringel JS, Sturm R. National estimates of mental health utilization and expenditures for children in 1998. J Behav Health Serv Res. 2001;28(3):319-333.
25. Jacobson JW, Mulick JA System and cost research issues in treatments for people with autistic disorders. J Autism Dev Disord. 2000;30(6):585-593.
26. Newschaffer CJ, Curran LK Autism: An emerging public health problem. Public Health Rep. 2003;118(5):393-399.
27. Iezzoni LI Using administrative data to study persons with disabilities. Milbank Q. 2002;80(2):347-379.
28. Jacobson JMJ. Cost-benefit estimates for early intensive behavioral intervention for Young Children With Autism- General Model and Single State Case. Behav Interven. 1998;13:201-226.